Pilot study evaluating the safety and efficacy of open-label olanzapine monotherapy in treatment refractory bipolar disorder mania
Phase of Trial: Phase III
Latest Information Update: 23 Sep 2016
At a glance
- Drugs Olanzapine (Primary)
- Indications Bipolar I disorders
- Focus Therapeutic Use
- 06 Dec 2007 Status changed from in progress to discontinued.
- 12 Jun 2007 Status changed from suspended to in progress.
- 02 Nov 2005 New trial record.